tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CABA Stock Latest News

Cabaletta Bio to Participate in Upcoming Investor Conferences in September
Press ReleasesCabaletta Bio to Participate in Upcoming Investor Conferences in September
23d ago
CABA
Cabaletta Bio price target lowered to $15 from $25 at Evercore ISI
PremiumThe Fly
Cabaletta Bio price target lowered to $15 from $25 at Evercore ISI
1M ago
CABA
Cabaletta Bio price target lowered to $20 from $35 at Wells Fargo
PremiumThe Fly
Cabaletta Bio price target lowered to $20 from $35 at Wells Fargo
1M ago
CABA
Cabaletta Bio price target lowered to $25 from $30 at H.C. Wainwright
PremiumThe Fly
Cabaletta Bio price target lowered to $25 from $30 at H.C. Wainwright
1M ago
CABA
Citi says Cabaletta views Grade 4 ICANS event as ‘potentially a one-off’
PremiumThe Fly
Citi says Cabaletta views Grade 4 ICANS event as ‘potentially a one-off’
1M ago
CABA
Cabaletta Bio Unveils Updated Corporate Strategy Details
PremiumCompany AnnouncementsCabaletta Bio Unveils Updated Corporate Strategy Details
1M ago
8K
CABA
Cabaletta Bio reports Q2 EPS (56c) consensus (55c)
Premium
The Fly
Cabaletta Bio reports Q2 EPS (56c) consensus (55c)
1M ago
CABA
Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
Premium
Press Releases
Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
1M ago
CABA
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
2M ago
ACET
ALLO
Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum
PremiumPress Releases
Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum
3M ago
CABA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
BPTH
CABA
Kyverna, Cabaletta selloffs an overreaction, says Wells Fargo
PremiumThe Fly
Kyverna, Cabaletta selloffs an overreaction, says Wells Fargo
3M ago
CABA
KYTX
Cabaletta Bio’s Promising Clinical Data Advance Autoimmune Therapy
PremiumCompany AnnouncementsCabaletta Bio’s Promising Clinical Data Advance Autoimmune Therapy
3M ago
8K
CABA
Cabaletta Bio reports clinical data from first two patients dosed with CABA-201
Premium
The Fly
Cabaletta Bio reports clinical data from first two patients dosed with CABA-201
3M ago
CABA
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
Premium
Press Releases
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
3M ago
CABA
Cabaletta Bio Reveals Insights in Updated Corporate Presentation
PremiumCompany Announcements
Cabaletta Bio Reveals Insights in Updated Corporate Presentation
4M ago
8K
CABA
Cabaletta Bio reports Q1 EPS (51c) , consensus (48c)
PremiumThe Fly
Cabaletta Bio reports Q1 EPS (51c) , consensus (48c)
4M ago
CABA
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
4M ago
CABA
Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
PremiumPress Releases
Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
4M ago
CABA
Citi reiterates Buy on Cabaletta, says too early to write off CAR-T
PremiumThe FlyCiti reiterates Buy on Cabaletta, says too early to write off CAR-T
5M ago
CABA
Cabaletta Bio price target raised to $30 from $26 at Citi
Premium
The Fly
Cabaletta Bio price target raised to $30 from $26 at Citi
6M ago
CABA
Cabaletta Bio price target raised to $33 from $31 at Morgan Stanley
Premium
The Fly
Cabaletta Bio price target raised to $33 from $31 at Morgan Stanley
6M ago
CABA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >